Targeting transcription factors for cancer treatment

M Lambert, S Jambon, S Depauw… - Molecules, 2018 - mdpi.com
Transcription factors are involved in a large number of human diseases such as cancers for
which they account for about 20% of all oncogenes identified so far. For long time, with the …

[HTML][HTML] Diabetes and pancreatic cancer: Exploring the two-way traffic

A Roy, J Sahoo, S Kamalanathan, D Naik… - World journal of …, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer (PC) is often associated with a poor prognosis. Long-standing diabetes
mellitus is considered as an important risk factor for its development. This risk can be …

Potential role of ANGPTL4 in the cross talk between metabolism and cancer through PPAR signaling pathway

L La Paglia, A Listì, S Caruso, V Amodeo… - PPAR …, 2017 - Wiley Online Library
The angiopoietin‐like 4 (ANGPTL4) protein belongs to a superfamily of secreted proteins
structurally related to factors modulating angiogenesis known as angiopoietins. At first …

Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting

R Pothuraju, S Rachagani, WM Junker… - Journal of Experimental …, 2018 - Springer
Background Pancreatic cancer (PC) is among foremost causes of cancer related deaths
worldwide due to generic symptoms, lack of effective screening strategies and resistance to …

Diabetes mellitus and obesity as risk factors for pancreatic cancer

G Eibl, Z Cruz-Monserrate, M Korc, MS Petrov… - Journal of the Academy …, 2018 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest types of cancer. The
worldwide estimates of its incidence and mortality in the general population are eight cases …

The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity

S Yousefnia, S Momenzadeh, FS Forootan, K Ghaedi… - Gene, 2018 - Elsevier
Peroxisome proliferator-activated receptor γ (PPARγ) belongs to the nuclear receptor
superfamily of PPARs (PPARα, PPARβ/δ, PPARγ). Numerous studies have concentrated on …

Pleiotropic actions of peroxisome proliferator-activated receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: current evidence and …

AS Laganà, SG Vitale, A Nigro, V Sofo… - International journal of …, 2016 - mdpi.com
Background: Peroxisome proliferator-activated receptors (PPARs) have demonstrated a lot
of important effects in the regulation of glucose and lipid metabolism and in the correct …

Linking bisphenol S to adverse outcome pathways using a combined text mining and systems biology approach

JC Carvaillo, R Barouki, X Coumoul… - Environmental health …, 2019 - ehp.niehs.nih.gov
Background: Available toxicity data can be optimally interpreted if they are integrated using
computational approaches such as systems biology modeling. Such approaches are …

Peroxisome proliferator‐activated receptor modulation during metabolic diseases and cancers: master and minions

SG Vitale, AS Laganà, A Nigro, VL La Rosa… - PPAR …, 2016 - Wiley Online Library
The prevalence of obesity and metabolic diseases (such as type 2 diabetes mellitus,
dyslipidaemia, and cardiovascular diseases) has increased in the last decade, in both …

Cannabinoids and PPAR ligands: the future in treatment of polycystic ovary syndrome women with obesity and reduced fertility

P Przybycień, D Gąsior-Perczak, W Placha - Cells, 2022 - mdpi.com
Cannabinoids (CBs) are used to treat chronic pain, chemotherapy-induced nausea and
vomiting, and multiple sclerosis spasticity. Recently, the medicinal use of CBs has attracted …